SETDB1 and cancer: It is not fully understood to what extent SETDB1’s role in cancer development can be attributed to its ability to repress the expression of TEs, but SETDB1 loss has been shown to result in TE activation and loss of cellular fitness driven by a viral mimicry response in some cancers (Cuellar et al., 2017; Gu et al., 2021).